The effect of PLGA-based hydrogel scaffold for improving the drug maximum-tolerated dose for in situ osteosarcoma treatment
[Display omitted] •PLGA-PEG-PLGA-based hydrogel shows good injectable and biodegradable properties.•Gel depot obviously prolongs the drug remaining time in the tumor site.•The maximum tolerated dose of DOX is improved by the PLGA-PEG-PLGA-based hydrogel.•This localized drug delivery strategy results...
Saved in:
Published in | Colloids and surfaces, B, Biointerfaces Vol. 172; pp. 387 - 394 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
Netherlands
Elsevier B.V
01.12.2018
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | [Display omitted]
•PLGA-PEG-PLGA-based hydrogel shows good injectable and biodegradable properties.•Gel depot obviously prolongs the drug remaining time in the tumor site.•The maximum tolerated dose of DOX is improved by the PLGA-PEG-PLGA-based hydrogel.•This localized drug delivery strategy results in a better outcome than free drug.
Although hydrogel-based therapeutic agents have shown great potential for localized cancer treatments, the maximum tolerated dose (MTD) of these methods remains uncertain. To confirm this, doxorubicin (DOX) loaded PLGA-PEG-PLGA hydrogel was employed to investigate the MTD of DOX for localized osteosarcoma treatment. This hydrogel showed good injectable and biodegradable properties in vivo. And the drug remaining time was also obviously prolonged in the tumor site. Different doses of DOX (5.0, 15, 30 mg/kg) with/without hydrogel were adopted to the treatment of tumor-bearing mice. Despite both localized administrations of 5.0 mg/kg DOX showing no obvious systemic toxicity, this dose failed to control the persistent growth of tumors or prolong the survival time in comparison with the control groups. Localized administration of 30 mg/kg DOX showed a high efficacy for suppressing tumor growth, but exhibited obvious body weight losing at the same time. Correspondingly, the DOX-loaded hydrogel with the dose of 15 mg/kg achieved significantly improved anti-tumor efficacy and prolonged mean survival time compared with both the free DOX (15 mg/kg) and other control groups. Furthermore, during the whole therapeutic process, the mice showed no obvious body weight loss, major organs damage or death in this group. The MTD of DOX-loaded agent based on the PLGA-PEG-PLGA hydrogel gave a 2-fold increase compared to the MTD of free DOX (7.5 mg/kg, intravenous injection) for the mouse without significant systemic toxicity. |
---|---|
AbstractList | Although hydrogel-based therapeutic agents have shown great potential for localized cancer treatments, the maximum tolerated dose (MTD) of these methods remains uncertain. To confirm this, doxorubicin (DOX) loaded PLGA-PEG-PLGA hydrogel was employed to investigate the MTD of DOX for localized osteosarcoma treatment. This hydrogel showed good injectable and biodegradable properties in vivo. And the drug remaining time was also obviously prolonged in the tumor site. Different doses of DOX (5.0, 15, 30 mg/kg) with/without hydrogel were adopted to the treatment of tumor-bearing mice. Despite both localized administrations of 5.0 mg/kg DOX showing no obvious systemic toxicity, this dose failed to control the persistent growth of tumors or prolong the survival time in comparison with the control groups. Localized administration of 30 mg/kg DOX showed a high efficacy for suppressing tumor growth, but exhibited obvious body weight losing at the same time. Correspondingly, the DOX-loaded hydrogel with the dose of 15 mg/kg achieved significantly improved anti-tumor efficacy and prolonged mean survival time compared with both the free DOX (15 mg/kg) and other control groups. Furthermore, during the whole therapeutic process, the mice showed no obvious body weight loss, major organs damage or death in this group. The MTD of DOX-loaded agent based on the PLGA-PEG-PLGA hydrogel gave a 2-fold increase compared to the MTD of free DOX (7.5 mg/kg, intravenous injection) for the mouse without significant systemic toxicity. [Display omitted] •PLGA-PEG-PLGA-based hydrogel shows good injectable and biodegradable properties.•Gel depot obviously prolongs the drug remaining time in the tumor site.•The maximum tolerated dose of DOX is improved by the PLGA-PEG-PLGA-based hydrogel.•This localized drug delivery strategy results in a better outcome than free drug. Although hydrogel-based therapeutic agents have shown great potential for localized cancer treatments, the maximum tolerated dose (MTD) of these methods remains uncertain. To confirm this, doxorubicin (DOX) loaded PLGA-PEG-PLGA hydrogel was employed to investigate the MTD of DOX for localized osteosarcoma treatment. This hydrogel showed good injectable and biodegradable properties in vivo. And the drug remaining time was also obviously prolonged in the tumor site. Different doses of DOX (5.0, 15, 30 mg/kg) with/without hydrogel were adopted to the treatment of tumor-bearing mice. Despite both localized administrations of 5.0 mg/kg DOX showing no obvious systemic toxicity, this dose failed to control the persistent growth of tumors or prolong the survival time in comparison with the control groups. Localized administration of 30 mg/kg DOX showed a high efficacy for suppressing tumor growth, but exhibited obvious body weight losing at the same time. Correspondingly, the DOX-loaded hydrogel with the dose of 15 mg/kg achieved significantly improved anti-tumor efficacy and prolonged mean survival time compared with both the free DOX (15 mg/kg) and other control groups. Furthermore, during the whole therapeutic process, the mice showed no obvious body weight loss, major organs damage or death in this group. The MTD of DOX-loaded agent based on the PLGA-PEG-PLGA hydrogel gave a 2-fold increase compared to the MTD of free DOX (7.5 mg/kg, intravenous injection) for the mouse without significant systemic toxicity. |
Author | Yang, Zhiming Liu, Jianguo Chen, Xuesi Yu, Shuangjiang Li, Dongsong Gong, Yubao Zang, Junting |
Author_xml | – sequence: 1 givenname: Zhiming surname: Yang fullname: Yang, Zhiming organization: Department of Orthopaedics, The First Hospital of Jilin University, Changchun 130021, PR China – sequence: 2 givenname: Shuangjiang surname: Yu fullname: Yu, Shuangjiang email: yushuangjiang@ciac.ac.cn organization: Key Laboratory of Polymer Ecomaterials, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun 130022, PR China – sequence: 3 givenname: Dongsong surname: Li fullname: Li, Dongsong organization: Department of Orthopaedics, The First Hospital of Jilin University, Changchun 130021, PR China – sequence: 4 givenname: Yubao surname: Gong fullname: Gong, Yubao organization: Department of Orthopaedics, The First Hospital of Jilin University, Changchun 130021, PR China – sequence: 5 givenname: Junting surname: Zang fullname: Zang, Junting organization: Department of Orthopaedics, The First Hospital of Jilin University, Changchun 130021, PR China – sequence: 6 givenname: Jianguo surname: Liu fullname: Liu, Jianguo email: jgliu.2005@aliyun.com organization: Department of Orthopaedics, The First Hospital of Jilin University, Changchun 130021, PR China – sequence: 7 givenname: Xuesi orcidid: 0000-0003-3542-9256 surname: Chen fullname: Chen, Xuesi organization: Key Laboratory of Polymer Ecomaterials, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun 130022, PR China |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/30193198$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkMtOLCEURYnRaPv4BcPwTqqFgqbomcb4SjrRgY4JBYeWTlEoUEbjz4tpvVOTE5iszWGvQ7Q7xhEQOqVkTgkVZ5u5iUOekuvnLaFyTupwuYNmVHas4Ux0u2hGlm3XdJ1YHKDDnDeEkJbTbh8dMEKXjC7lDH0-PgMG58AUHB1-WN1cNL3OYPHzh01xDQPORjsXB4tdTNiHlxTf_LjGpQZtmtY46HcfptCUOEDSpUZtzLClR5x9mXDMBWLWycSgcUmgS4CxHKM9p4cMJz_3EXq6vnq8vG1W9zd3lxerxvCOlqYlohWMA3P1pL2uJaQBSwWA6CmDpaidjaOC65Zrp42ldqF5L40GBsKwI_Rv-279-usEuajgs4Fh0CPEKau2Gm2FlHRRUbFFTYo5J3DqJfmg04eiRH2LVxv1K159i1ekDpc1ePqzY-oD2P-xX9MVON8CUJu-eUgqGw9jLeJTla9s9H_t-AL0Zpw1 |
CitedBy_id | crossref_primary_10_1016_j_polymdegradstab_2021_109535 crossref_primary_10_1016_j_actbio_2020_10_006 crossref_primary_10_1016_j_jconrel_2020_12_008 crossref_primary_10_1158_0008_5472_CAN_22_0734 crossref_primary_10_1002_mabi_202200114 crossref_primary_10_1021_jacs_2c09663 crossref_primary_10_1016_j_reactfunctpolym_2019_02_014 crossref_primary_10_1016_j_biomaterials_2019_05_031 crossref_primary_10_3390_ijms20030618 crossref_primary_10_1016_j_eurpolymj_2019_109396 crossref_primary_10_3390_polym14163368 crossref_primary_10_3390_pharmaceutics11090486 crossref_primary_10_1007_s13346_022_01191_w crossref_primary_10_1016_j_ijbiomac_2019_04_131 crossref_primary_10_1038_s41413_021_00139_z crossref_primary_10_1080_09205063_2023_2283910 crossref_primary_10_1002_adhm_202300105 crossref_primary_10_2174_2667387816666221005102931 crossref_primary_10_1615_CritRevBiomedEng_2023043780 crossref_primary_10_1016_j_msec_2021_111875 crossref_primary_10_3389_fbioe_2023_1199343 crossref_primary_10_1016_j_actbio_2023_03_044 crossref_primary_10_1016_j_cej_2020_126879 crossref_primary_10_3389_fbioe_2022_1042625 crossref_primary_10_1016_j_ijpharm_2019_118799 crossref_primary_10_3390_bioengineering6040107 crossref_primary_10_1177_20417314231170371 crossref_primary_10_1016_j_eng_2024_01_031 crossref_primary_10_1016_j_isci_2021_102475 |
Cites_doi | 10.1016/j.biomaterials.2015.03.021 10.1016/j.jconrel.2015.03.001 10.1038/natrevmats.2016.71 10.1016/j.jconrel.2009.10.003 10.1039/C7CP07240F 10.1016/j.jconrel.2013.10.006 10.1016/j.ejca.2012.09.011 10.1016/j.ejps.2015.12.031 10.1002/mabi.200900298 10.1586/14737140.6.7.1075 10.1016/S1470-2045(10)70062-0 10.1039/c2bm00159d 10.1038/nmat4707 10.1016/j.ctrv.2010.02.003 10.1200/JCO.2005.00.554 10.1166/jnn.2014.8765 10.1016/j.biomaterials.2014.01.018 10.1002/ijc.24320 10.1002/anie.200503575 10.3322/caac.21219 10.1056/NEJM197411072911903 10.1016/S0168-3659(99)00061-9 10.1002/1521-3927(20010501)22:8<587::AID-MARC587>3.0.CO;2-8 10.1039/b713009k 10.1056/NEJM200506093522321 10.1016/j.jconrel.2008.01.005 10.1016/j.actbio.2017.05.053 10.1200/JCO.2012.43.4233 10.1016/j.biomaterials.2009.05.035 10.1016/j.biomaterials.2009.02.040 10.1021/ar200162j 10.1016/j.drudis.2016.11.005 10.1021/la400268p 10.1016/j.ijpharm.2007.07.026 10.1016/j.ijpharm.2012.08.007 10.1038/ncomms2921 10.1016/j.biomaterials.2014.06.045 10.1016/j.ijpharm.2005.01.017 10.1016/j.ctrv.2013.11.006 |
ContentType | Journal Article |
Copyright | 2018 Elsevier B.V. Copyright © 2018 Elsevier B.V. All rights reserved. |
Copyright_xml | – notice: 2018 Elsevier B.V. – notice: Copyright © 2018 Elsevier B.V. All rights reserved. |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 |
DOI | 10.1016/j.colsurfb.2018.08.048 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Engineering Anatomy & Physiology Chemistry |
EISSN | 1873-4367 |
EndPage | 394 |
ExternalDocumentID | 10_1016_j_colsurfb_2018_08_048 30193198 S0927776518305800 |
Genre | Journal Article |
GroupedDBID | --- --K --M -~X .~1 0R~ 1B1 1~. 1~5 4.4 457 4G. 53G 5GY 5VS 7-5 71M 8P~ 9JM 9JN AABXZ AACTN AAEDT AAEDW AAEPC AAIAV AAIKJ AAKOC AALRI AAOAW AAQFI AARLI AAXUO ABGSF ABMAC ABNEU ABNUV ABUDA ABXRA ABYKQ ACDAQ ACFVG ACGFS ACNCT ACRLP ADBBV ADECG ADEWK ADEZE ADUVX AEBSH AEHWI AEKER AEZYN AFKWA AFRZQ AFTJW AFXIZ AFZHZ AGHFR AGUBO AGYEJ AHHHB AHPOS AIEXJ AIKHN AITUG AIVDX AJOXV AJSZI AKURH ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ AXJTR BKOJK BLXMC CS3 DOVZS EBS EFJIC EFLBG EJD ENUVR EO8 EO9 EP2 EP3 F5P FDB FIRID FLBIZ FNPLU FYGXN G-Q GBLVA IHE J1W KOM LX7 M24 M41 MAGPM MO0 N9A O-L O9- OAUVE OGIMB OZT P-8 P-9 P2P PC. Q38 RIG RNS ROL RPZ SDF SDG SDP SES SPC SSG SSK SSM SSQ SSU SSZ T5K WH7 ~02 ~G- AAXKI CGR CUY CVF ECM EIF NPM 29F AAQXK AAYXX ABFNM ABXDB ACNNM ADMUD AFJKZ AGRDE AI. ASPBG AVWKF AZFZN BBWZM CITATION FEDTE FGOYB G-2 HLY HVGLF HZ~ NDZJH R2- SCB SCE SEW SMS VH1 WUQ 7X8 |
ID | FETCH-LOGICAL-c471t-2062634e3f6341ba0248ced16ee6b13e96187cf164a24afacd1d5a4b8cae3e6c3 |
IEDL.DBID | AIKHN |
ISSN | 0927-7765 |
IngestDate | Fri Aug 16 03:52:08 EDT 2024 Thu Sep 26 16:11:27 EDT 2024 Sat Sep 28 08:33:51 EDT 2024 Fri Feb 23 02:47:26 EST 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Keywords | Maximum tolerated dose Localized drug delivery Injectable hydrogel Cancer therapy |
Language | English |
License | Copyright © 2018 Elsevier B.V. All rights reserved. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c471t-2062634e3f6341ba0248ced16ee6b13e96187cf164a24afacd1d5a4b8cae3e6c3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ORCID | 0000-0003-3542-9256 |
PMID | 30193198 |
PQID | 2101268815 |
PQPubID | 23479 |
PageCount | 8 |
ParticipantIDs | proquest_miscellaneous_2101268815 crossref_primary_10_1016_j_colsurfb_2018_08_048 pubmed_primary_30193198 elsevier_sciencedirect_doi_10_1016_j_colsurfb_2018_08_048 |
PublicationCentury | 2000 |
PublicationDate | 2018-12-01 |
PublicationDateYYYYMMDD | 2018-12-01 |
PublicationDate_xml | – month: 12 year: 2018 text: 2018-12-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | Netherlands |
PublicationPlace_xml | – name: Netherlands |
PublicationTitle | Colloids and surfaces, B, Biointerfaces |
PublicationTitleAlternate | Colloids Surf B Biointerfaces |
PublicationYear | 2018 |
Publisher | Elsevier B.V |
Publisher_xml | – name: Elsevier B.V |
References | Jeong, Bae, Zentner, Kim (bib0170) 1999; 62 Chen, Wu, Sun, Dong, Wang (bib0195) 2013; 29 Li, Mooney (bib0100) 2016; 1 Biswas, Kumari, Lakhani, Ghosh (bib0095) 2016; 83 Janeway, Grier (bib0080) 2010; 11 Chou, Gorlick (bib0045) 2006; 6 Yu, Ci, Zhou, Zeng, Ding (bib0130) 2013; 1 Lammers, Subr, Ulbrich, Peschke, Huber, Hennink, Storm (bib0210) 2009; 30 Stiller, Trama, Serrain, Rossi, Navarro, Chirlaque, Casali, RARECARE Working Group (bib0040) 2013; 49 Xun, Li, Wang, Huang, Cheng, Zhang, Zhuo (bib0120) 2009; 9 Gjerde, Zhu, Nystrom, Knudsen (bib0125) 2018; 24 Conde, Oliva, Zhang, Artzi (bib0090) 2016; 15 Yu, Zhang, Ding (bib0160) 2006; 45 Park, Joo, Choi, Jeong (bib0110) 2012; 45 Yu, Chang, Zhang, Ding (bib0155) 2007; 348 Deepa, Singha, Panda (bib0070) 2014; 14 Pang, Qiao, Janssen (bib0065) 2013; 4 Marshall (bib0135) 2012; 30 Kai, Keeler, Perry, Reuter, LLuft, O’Neal, Zamboni, DeSimone (bib0140) 2015; 204 Ma, He, Cheng, Li, Gong, Liu, Tian, Chen (bib0185) 2014; 35 Al-Abd, Song, Kuh (bib0115) 2010; 142 Wei, Chen, Zhao, Ding, Chen (bib0205) 2017; 58 Luetke, Meyers, Lewis (bib0050) 2014; 40 Kaatsch (bib0020) 2010; 36 Gatta, Capocaccia, Stiller, Kaatsch, Berrino, Terenziani, EUROCARE Working Group (bib0010) 2005; 23 Qiao, Chen, Ma, Liu (bib0180) 2005; 294 Ward, DeSantis, Robbins, Kohler, Jemal (bib0005) 2014; 64 Lee, Shim, Kim, Lee, Park, Chang (bib0150) 2001; 22 Zhu, Li, Liu, Chen, Xi (bib0190) 2012; 437 Geller, Gorlick (bib0015) 2010; 8 Ta, Larson, Choong, Dunstan (bib0060) 2009; 30 Alexander, Ajazuddin, Khan, Saraf (bib0105) 2013; 172 He, Kim, Lee (bib0175) 2008; 127 Li, Tang, Lv, Song, Hong, Jing, Zhang, Chen (bib0145) 2014; 35 Zhang, Ding, Sun, Sun, Zhuang, Chang, Wang, Chen (bib0200) 2015; 49 Yu, Ding (bib0165) 2008; 37 Cagel, Grotz, Bernabeu, Moretton, Chippetta (bib0085) 2017; 22 Mirabello, Trosisi, Savage (bib0025) 2009; 125 Hayek, Speakman, Rehmus (bib0075) 2005; 352 Gatta, Botta, Rossi, Aareleid, Bielska-Lasota, Clavel, Dimitrova, Jakab, Kaatsh, Lacour, Mallone, Marcos-Gragera, Minicozzi, Sanchez-Perez, Sant, Santaquilani, Stiller, Tavilla, Trama, Visser, Peris-Bonet (bib0035) 2014; 12 Olstad, Gautvik, Reppe (bib0030) 2003; 23 Cortes, Holland, Wang, Sinks, Blom, Senn, Bank, Glidewell (bib0055) 1974; 291 Xu, Ding, Xiao, Li, Zhuang, Chen (bib0215) 2015; 54 Pang (10.1016/j.colsurfb.2018.08.048_bib0065) 2013; 4 Olstad (10.1016/j.colsurfb.2018.08.048_bib0030) 2003; 23 Biswas (10.1016/j.colsurfb.2018.08.048_bib0095) 2016; 83 He (10.1016/j.colsurfb.2018.08.048_bib0175) 2008; 127 Hayek (10.1016/j.colsurfb.2018.08.048_bib0075) 2005; 352 Yu (10.1016/j.colsurfb.2018.08.048_bib0165) 2008; 37 Zhu (10.1016/j.colsurfb.2018.08.048_bib0190) 2012; 437 Jeong (10.1016/j.colsurfb.2018.08.048_bib0170) 1999; 62 Geller (10.1016/j.colsurfb.2018.08.048_bib0015) 2010; 8 Gjerde (10.1016/j.colsurfb.2018.08.048_bib0125) 2018; 24 Al-Abd (10.1016/j.colsurfb.2018.08.048_bib0115) 2010; 142 Luetke (10.1016/j.colsurfb.2018.08.048_bib0050) 2014; 40 Cortes (10.1016/j.colsurfb.2018.08.048_bib0055) 1974; 291 Lee (10.1016/j.colsurfb.2018.08.048_bib0150) 2001; 22 Yu (10.1016/j.colsurfb.2018.08.048_bib0155) 2007; 348 Wei (10.1016/j.colsurfb.2018.08.048_bib0205) 2017; 58 Lammers (10.1016/j.colsurfb.2018.08.048_bib0210) 2009; 30 Li (10.1016/j.colsurfb.2018.08.048_bib0100) 2016; 1 Zhang (10.1016/j.colsurfb.2018.08.048_bib0200) 2015; 49 Cagel (10.1016/j.colsurfb.2018.08.048_bib0085) 2017; 22 Ma (10.1016/j.colsurfb.2018.08.048_bib0185) 2014; 35 Ward (10.1016/j.colsurfb.2018.08.048_bib0005) 2014; 64 Mirabello (10.1016/j.colsurfb.2018.08.048_bib0025) 2009; 125 Gatta (10.1016/j.colsurfb.2018.08.048_bib0035) 2014; 12 Kai (10.1016/j.colsurfb.2018.08.048_bib0140) 2015; 204 Gatta (10.1016/j.colsurfb.2018.08.048_bib0010) 2005; 23 Qiao (10.1016/j.colsurfb.2018.08.048_bib0180) 2005; 294 Chen (10.1016/j.colsurfb.2018.08.048_bib0195) 2013; 29 Conde (10.1016/j.colsurfb.2018.08.048_bib0090) 2016; 15 Park (10.1016/j.colsurfb.2018.08.048_bib0110) 2012; 45 Deepa (10.1016/j.colsurfb.2018.08.048_bib0070) 2014; 14 Xu (10.1016/j.colsurfb.2018.08.048_bib0215) 2015; 54 Ta (10.1016/j.colsurfb.2018.08.048_bib0060) 2009; 30 Stiller (10.1016/j.colsurfb.2018.08.048_bib0040) 2013; 49 Yu (10.1016/j.colsurfb.2018.08.048_bib0160) 2006; 45 Chou (10.1016/j.colsurfb.2018.08.048_bib0045) 2006; 6 Marshall (10.1016/j.colsurfb.2018.08.048_bib0135) 2012; 30 Xun (10.1016/j.colsurfb.2018.08.048_bib0120) 2009; 9 Li (10.1016/j.colsurfb.2018.08.048_bib0145) 2014; 35 Yu (10.1016/j.colsurfb.2018.08.048_bib0130) 2013; 1 Janeway (10.1016/j.colsurfb.2018.08.048_bib0080) 2010; 11 Kaatsch (10.1016/j.colsurfb.2018.08.048_bib0020) 2010; 36 Alexander (10.1016/j.colsurfb.2018.08.048_bib0105) 2013; 172 |
References_xml | – volume: 22 start-page: 587 year: 2001 end-page: 592 ident: bib0150 publication-title: Macromol. Rapid Commun. contributor: fullname: Chang – volume: 58 start-page: 44 year: 2017 end-page: 53 ident: bib0205 publication-title: Acta Biomater. contributor: fullname: Chen – volume: 62 start-page: 109 year: 1999 end-page: 114 ident: bib0170 publication-title: J. Control. Release contributor: fullname: Kim – volume: 8 start-page: 705 year: 2010 end-page: 718 ident: bib0015 publication-title: Clin. Adv. Hematol. Oncol. contributor: fullname: Gorlick – volume: 291 start-page: 998 year: 1974 end-page: 1000 ident: bib0055 publication-title: N. Engl. J. Med. contributor: fullname: Glidewell – volume: 29 start-page: 3721 year: 2013 end-page: 3729 ident: bib0195 publication-title: Langmuir contributor: fullname: Wang – volume: 12 start-page: e52 year: 2014 ident: bib0035 publication-title: Lancet Oncol. contributor: fullname: Peris-Bonet – volume: 45 start-page: 424 year: 2012 end-page: 433 ident: bib0110 publication-title: Acc. Chem. Res. contributor: fullname: Jeong – volume: 1 start-page: 411 year: 2013 end-page: 420 ident: bib0130 publication-title: Biomater. Sci. contributor: fullname: Ding – volume: 352 start-page: 2456 year: 2005 end-page: 2457 ident: bib0075 publication-title: N. Engl. J. Med. contributor: fullname: Rehmus – volume: 15 start-page: 1128 year: 2016 end-page: 1138 ident: bib0090 publication-title: Nat. Mater. contributor: fullname: Artzi – volume: 40 start-page: 523 year: 2014 end-page: 532 ident: bib0050 publication-title: Cancer Treat. Rev. contributor: fullname: Lewis – volume: 23 start-page: 2201 year: 2003 end-page: 2216 ident: bib0030 publication-title: Anticancer Res. contributor: fullname: Reppe – volume: 204 start-page: 70 year: 2015 end-page: 77 ident: bib0140 publication-title: J. Control. Release contributor: fullname: DeSimone – volume: 37 start-page: 1473 year: 2008 end-page: 1481 ident: bib0165 publication-title: Chem. Soc. Rev. contributor: fullname: Ding – volume: 127 start-page: 189 year: 2008 end-page: 207 ident: bib0175 publication-title: J. Control. Release contributor: fullname: Lee – volume: 49 start-page: 268 year: 2015 end-page: 269 ident: bib0200 publication-title: Mater. Sci. Eng. C contributor: fullname: Chen – volume: 30 start-page: 4815 year: 2009 end-page: 4823 ident: bib0060 publication-title: Biomaterials contributor: fullname: Dunstan – volume: 30 start-page: 2815 year: 2012 end-page: 2816 ident: bib0135 publication-title: J. Clin. Oncol. contributor: fullname: Marshall – volume: 125 start-page: 229 year: 2009 end-page: 234 ident: bib0025 publication-title: Int. J. Cancer contributor: fullname: Savage – volume: 14 start-page: 892 year: 2014 end-page: 904 ident: bib0070 publication-title: J. Nanosci. Nanotechnol. contributor: fullname: Panda – volume: 30 start-page: 3466 year: 2009 end-page: 3475 ident: bib0210 publication-title: Biomaterials contributor: fullname: Storm – volume: 437 start-page: 11 year: 2012 end-page: 19 ident: bib0190 publication-title: Int. J. Pharm. contributor: fullname: Xi – volume: 49 start-page: 684 year: 2013 end-page: 695 ident: bib0040 publication-title: Eur. J. Cancer contributor: fullname: RARECARE Working Group – volume: 6 start-page: 1075 year: 2006 end-page: 1085 ident: bib0045 publication-title: Expert Rev. Anticancer Ther. contributor: fullname: Gorlick – volume: 4 start-page: 1908 year: 2013 ident: bib0065 publication-title: Nat. Commun. contributor: fullname: Janssen – volume: 24 start-page: 2585 year: 2018 end-page: 2596 ident: bib0125 publication-title: Phys. Chem. Chem. Phys. contributor: fullname: Knudsen – volume: 36 start-page: 277 year: 2010 end-page: 285 ident: bib0020 publication-title: Cancer Treat. Rev. contributor: fullname: Kaatsch – volume: 172 start-page: 715 year: 2013 end-page: 729 ident: bib0105 publication-title: J. Control. Release contributor: fullname: Saraf – volume: 348 start-page: 95 year: 2007 end-page: 106 ident: bib0155 publication-title: Int. J. Pharm. contributor: fullname: Ding – volume: 64 start-page: 83 year: 2014 end-page: 103 ident: bib0005 publication-title: CA–Cancer J. Clin contributor: fullname: Jemal – volume: 142 start-page: 101 year: 2010 end-page: 107 ident: bib0115 publication-title: J. Control. Release contributor: fullname: Kuh – volume: 54 start-page: 72 year: 2015 end-page: 86 ident: bib0215 publication-title: Biomaterials contributor: fullname: Chen – volume: 1 start-page: 16071 year: 2016 ident: bib0100 publication-title: Nat. Rev. Mater. contributor: fullname: Mooney – volume: 45 start-page: 2232 year: 2006 end-page: 2235 ident: bib0160 publication-title: Angew. Chem. Int. Ed. Engl. contributor: fullname: Ding – volume: 35 start-page: 8723 year: 2014 end-page: 8734 ident: bib0185 publication-title: Biomaterials contributor: fullname: Chen – volume: 23 start-page: 3742 year: 2005 end-page: 3751 ident: bib0010 publication-title: J. Clin. Oncol. contributor: fullname: EUROCARE Working Group – volume: 83 start-page: 184 year: 2016 end-page: 202 ident: bib0095 publication-title: Eur. J. Pharm. Sci. contributor: fullname: Ghosh – volume: 35 start-page: 3851 year: 2014 end-page: 3864 ident: bib0145 publication-title: Biomaterials contributor: fullname: Chen – volume: 294 start-page: 103 year: 2005 end-page: 112 ident: bib0180 publication-title: Int. J. Pharm. contributor: fullname: Liu – volume: 9 start-page: 1219 year: 2009 end-page: 1226 ident: bib0120 publication-title: Macromol. Biosci. contributor: fullname: Zhuo – volume: 11 start-page: 670 year: 2010 end-page: 678 ident: bib0080 publication-title: Lancet Oncol. contributor: fullname: Grier – volume: 22 start-page: 270 year: 2017 end-page: 281 ident: bib0085 publication-title: Drug Discov. Today contributor: fullname: Chippetta – volume: 54 start-page: 72 year: 2015 ident: 10.1016/j.colsurfb.2018.08.048_bib0215 publication-title: Biomaterials doi: 10.1016/j.biomaterials.2015.03.021 contributor: fullname: Xu – volume: 204 start-page: 70 year: 2015 ident: 10.1016/j.colsurfb.2018.08.048_bib0140 publication-title: J. Control. Release doi: 10.1016/j.jconrel.2015.03.001 contributor: fullname: Kai – volume: 1 start-page: 16071 year: 2016 ident: 10.1016/j.colsurfb.2018.08.048_bib0100 publication-title: Nat. Rev. Mater. doi: 10.1038/natrevmats.2016.71 contributor: fullname: Li – volume: 142 start-page: 101 year: 2010 ident: 10.1016/j.colsurfb.2018.08.048_bib0115 publication-title: J. Control. Release doi: 10.1016/j.jconrel.2009.10.003 contributor: fullname: Al-Abd – volume: 23 start-page: 2201 year: 2003 ident: 10.1016/j.colsurfb.2018.08.048_bib0030 publication-title: Anticancer Res. contributor: fullname: Olstad – volume: 24 start-page: 2585 year: 2018 ident: 10.1016/j.colsurfb.2018.08.048_bib0125 publication-title: Phys. Chem. Chem. Phys. doi: 10.1039/C7CP07240F contributor: fullname: Gjerde – volume: 172 start-page: 715 year: 2013 ident: 10.1016/j.colsurfb.2018.08.048_bib0105 publication-title: J. Control. Release doi: 10.1016/j.jconrel.2013.10.006 contributor: fullname: Alexander – volume: 49 start-page: 684 year: 2013 ident: 10.1016/j.colsurfb.2018.08.048_bib0040 publication-title: Eur. J. Cancer doi: 10.1016/j.ejca.2012.09.011 contributor: fullname: Stiller – volume: 83 start-page: 184 year: 2016 ident: 10.1016/j.colsurfb.2018.08.048_bib0095 publication-title: Eur. J. Pharm. Sci. doi: 10.1016/j.ejps.2015.12.031 contributor: fullname: Biswas – volume: 9 start-page: 1219 year: 2009 ident: 10.1016/j.colsurfb.2018.08.048_bib0120 publication-title: Macromol. Biosci. doi: 10.1002/mabi.200900298 contributor: fullname: Xun – volume: 6 start-page: 1075 year: 2006 ident: 10.1016/j.colsurfb.2018.08.048_bib0045 publication-title: Expert Rev. Anticancer Ther. doi: 10.1586/14737140.6.7.1075 contributor: fullname: Chou – volume: 11 start-page: 670 year: 2010 ident: 10.1016/j.colsurfb.2018.08.048_bib0080 publication-title: Lancet Oncol. doi: 10.1016/S1470-2045(10)70062-0 contributor: fullname: Janeway – volume: 1 start-page: 411 year: 2013 ident: 10.1016/j.colsurfb.2018.08.048_bib0130 publication-title: Biomater. Sci. doi: 10.1039/c2bm00159d contributor: fullname: Yu – volume: 15 start-page: 1128 year: 2016 ident: 10.1016/j.colsurfb.2018.08.048_bib0090 publication-title: Nat. Mater. doi: 10.1038/nmat4707 contributor: fullname: Conde – volume: 49 start-page: 268 year: 2015 ident: 10.1016/j.colsurfb.2018.08.048_bib0200 publication-title: Mater. Sci. Eng. C contributor: fullname: Zhang – volume: 36 start-page: 277 year: 2010 ident: 10.1016/j.colsurfb.2018.08.048_bib0020 publication-title: Cancer Treat. Rev. doi: 10.1016/j.ctrv.2010.02.003 contributor: fullname: Kaatsch – volume: 23 start-page: 3742 year: 2005 ident: 10.1016/j.colsurfb.2018.08.048_bib0010 publication-title: J. Clin. Oncol. doi: 10.1200/JCO.2005.00.554 contributor: fullname: Gatta – volume: 14 start-page: 892 year: 2014 ident: 10.1016/j.colsurfb.2018.08.048_bib0070 publication-title: J. Nanosci. Nanotechnol. doi: 10.1166/jnn.2014.8765 contributor: fullname: Deepa – volume: 35 start-page: 3851 year: 2014 ident: 10.1016/j.colsurfb.2018.08.048_bib0145 publication-title: Biomaterials doi: 10.1016/j.biomaterials.2014.01.018 contributor: fullname: Li – volume: 125 start-page: 229 year: 2009 ident: 10.1016/j.colsurfb.2018.08.048_bib0025 publication-title: Int. J. Cancer doi: 10.1002/ijc.24320 contributor: fullname: Mirabello – volume: 45 start-page: 2232 year: 2006 ident: 10.1016/j.colsurfb.2018.08.048_bib0160 publication-title: Angew. Chem. Int. Ed. Engl. doi: 10.1002/anie.200503575 contributor: fullname: Yu – volume: 64 start-page: 83 year: 2014 ident: 10.1016/j.colsurfb.2018.08.048_bib0005 publication-title: CA–Cancer J. Clin doi: 10.3322/caac.21219 contributor: fullname: Ward – volume: 291 start-page: 998 year: 1974 ident: 10.1016/j.colsurfb.2018.08.048_bib0055 publication-title: N. Engl. J. Med. doi: 10.1056/NEJM197411072911903 contributor: fullname: Cortes – volume: 62 start-page: 109 year: 1999 ident: 10.1016/j.colsurfb.2018.08.048_bib0170 publication-title: J. Control. Release doi: 10.1016/S0168-3659(99)00061-9 contributor: fullname: Jeong – volume: 22 start-page: 587 year: 2001 ident: 10.1016/j.colsurfb.2018.08.048_bib0150 publication-title: Macromol. Rapid Commun. doi: 10.1002/1521-3927(20010501)22:8<587::AID-MARC587>3.0.CO;2-8 contributor: fullname: Lee – volume: 8 start-page: 705 year: 2010 ident: 10.1016/j.colsurfb.2018.08.048_bib0015 publication-title: Clin. Adv. Hematol. Oncol. contributor: fullname: Geller – volume: 37 start-page: 1473 year: 2008 ident: 10.1016/j.colsurfb.2018.08.048_bib0165 publication-title: Chem. Soc. Rev. doi: 10.1039/b713009k contributor: fullname: Yu – volume: 352 start-page: 2456 year: 2005 ident: 10.1016/j.colsurfb.2018.08.048_bib0075 publication-title: N. Engl. J. Med. doi: 10.1056/NEJM200506093522321 contributor: fullname: Hayek – volume: 127 start-page: 189 year: 2008 ident: 10.1016/j.colsurfb.2018.08.048_bib0175 publication-title: J. Control. Release doi: 10.1016/j.jconrel.2008.01.005 contributor: fullname: He – volume: 58 start-page: 44 year: 2017 ident: 10.1016/j.colsurfb.2018.08.048_bib0205 publication-title: Acta Biomater. doi: 10.1016/j.actbio.2017.05.053 contributor: fullname: Wei – volume: 30 start-page: 2815 year: 2012 ident: 10.1016/j.colsurfb.2018.08.048_bib0135 publication-title: J. Clin. Oncol. doi: 10.1200/JCO.2012.43.4233 contributor: fullname: Marshall – volume: 30 start-page: 4815 year: 2009 ident: 10.1016/j.colsurfb.2018.08.048_bib0060 publication-title: Biomaterials doi: 10.1016/j.biomaterials.2009.05.035 contributor: fullname: Ta – volume: 30 start-page: 3466 year: 2009 ident: 10.1016/j.colsurfb.2018.08.048_bib0210 publication-title: Biomaterials doi: 10.1016/j.biomaterials.2009.02.040 contributor: fullname: Lammers – volume: 45 start-page: 424 year: 2012 ident: 10.1016/j.colsurfb.2018.08.048_bib0110 publication-title: Acc. Chem. Res. doi: 10.1021/ar200162j contributor: fullname: Park – volume: 22 start-page: 270 year: 2017 ident: 10.1016/j.colsurfb.2018.08.048_bib0085 publication-title: Drug Discov. Today doi: 10.1016/j.drudis.2016.11.005 contributor: fullname: Cagel – volume: 29 start-page: 3721 year: 2013 ident: 10.1016/j.colsurfb.2018.08.048_bib0195 publication-title: Langmuir doi: 10.1021/la400268p contributor: fullname: Chen – volume: 12 start-page: e52 year: 2014 ident: 10.1016/j.colsurfb.2018.08.048_bib0035 publication-title: Lancet Oncol. contributor: fullname: Gatta – volume: 348 start-page: 95 year: 2007 ident: 10.1016/j.colsurfb.2018.08.048_bib0155 publication-title: Int. J. Pharm. doi: 10.1016/j.ijpharm.2007.07.026 contributor: fullname: Yu – volume: 437 start-page: 11 year: 2012 ident: 10.1016/j.colsurfb.2018.08.048_bib0190 publication-title: Int. J. Pharm. doi: 10.1016/j.ijpharm.2012.08.007 contributor: fullname: Zhu – volume: 4 start-page: 1908 year: 2013 ident: 10.1016/j.colsurfb.2018.08.048_bib0065 publication-title: Nat. Commun. doi: 10.1038/ncomms2921 contributor: fullname: Pang – volume: 35 start-page: 8723 year: 2014 ident: 10.1016/j.colsurfb.2018.08.048_bib0185 publication-title: Biomaterials doi: 10.1016/j.biomaterials.2014.06.045 contributor: fullname: Ma – volume: 294 start-page: 103 year: 2005 ident: 10.1016/j.colsurfb.2018.08.048_bib0180 publication-title: Int. J. Pharm. doi: 10.1016/j.ijpharm.2005.01.017 contributor: fullname: Qiao – volume: 40 start-page: 523 year: 2014 ident: 10.1016/j.colsurfb.2018.08.048_bib0050 publication-title: Cancer Treat. Rev. doi: 10.1016/j.ctrv.2013.11.006 contributor: fullname: Luetke |
SSID | ssj0002417 |
Score | 2.4605875 |
Snippet | [Display omitted]
•PLGA-PEG-PLGA-based hydrogel shows good injectable and biodegradable properties.•Gel depot obviously prolongs the drug remaining time in the... Although hydrogel-based therapeutic agents have shown great potential for localized cancer treatments, the maximum tolerated dose (MTD) of these methods... |
SourceID | proquest crossref pubmed elsevier |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 387 |
SubjectTerms | Animals Antineoplastic Agents - pharmacology Antineoplastic Agents - therapeutic use Cancer therapy Cell Death - drug effects Cell Line, Tumor Doxorubicin - chemistry Doxorubicin - pharmacology Doxorubicin - therapeutic use Drug Liberation Female Humans Hydrogels - chemistry Injectable hydrogel Localized drug delivery Maximum Tolerated Dose Mice, Inbred BALB C Osteosarcoma - drug therapy Osteosarcoma - pathology Phase Transition Polyesters - chemical synthesis Polyesters - chemistry Polyethylene Glycols - chemical synthesis Polyethylene Glycols - chemistry Rats, Wistar Tissue Scaffolds - chemistry |
Title | The effect of PLGA-based hydrogel scaffold for improving the drug maximum-tolerated dose for in situ osteosarcoma treatment |
URI | https://dx.doi.org/10.1016/j.colsurfb.2018.08.048 https://www.ncbi.nlm.nih.gov/pubmed/30193198 https://search.proquest.com/docview/2101268815 |
Volume | 172 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1La9wwEB6SzaHtIaSbPpK2QYXSm7rxWra0x2Vpsn0QCm0gNyHJUuKwtsLahoZAfntHfiwptPTQi8FGIwvNaGYkfTMD8E64KTMp01Q4binjsaYzpixNuXVJhi66VS1A9ixdnrPPF8nFFiyGWJgAq-x1f6fTW23df5n0szm5yfPJ9-PZlHOeJiiUxwn6Pduwg-aIsRHszD99WZ5tFDJ-baOmsT0NBA8Cha-x-1XVrJ0OKC_RZvMMpYD-bKP-5oO2tuhkD3Z7J5LMu3E-hS1bjmF_XuIGurgl70kL62zPy8fwaDGUdBvDkwfZB_fhDkWEdHgO4h359vV0ToNRy8jVbbb2l3ZFKqOc86uMoGtL8uH8gaDTSLJ1c0kK9TMvmoLWfhWSMyNp5ivbtS5JldcNCUEkvsLl5AtFNrD2Z3B-8vHHYkn7WgzUoPmqcTGFtDXMxg6fkVYhFRqyKEqtTXUU21A4hhuHmy81Zcopk0VZopgWRtnYpiZ-DqPSl_YlEI72MXaxDanEmDFaJOE6kxvGNPYViwOYDLMvb7qUG3LAol3LgV8y8EuGEpoMKWYDk-RvwiPRLvyT9u3AVYncCNclqrS-qeQ0pD5LhYiSA3jRsXszHlSLM1Re4vA__vwKHoe3DhvzGkb1urFv0MOp9RFsf7iPjno5_gXeMPza |
link.rule.ids | 315,786,790,4521,24144,27955,27956,45618,45712 |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwELZKORQOqGx5tLyMhLiZbTZO7D2uVi0LLBUSrdSbZTt2SbWJq00itULqb-9MHqVIIA5cckhsx_LYM2P7m28IeSf9hNuUGya9cIyL2LAp146lwvkkAxfd6RYge5QuTvjn0-R0g8yHWBiEVfa6v9Pprbbu34z70Rxf5Pn4-_50IoRIE5iU-wn4PffIffQGENf14foXzgNMVBszDaUZFr8TJnwOja-qZu0NYrxky-WJiYD-bKH-5oG2luhwmzzqXUg663r5mGy4ckR2ZiVsn4sr-p62oM72tHxEtuZDQrcReXiHe3CH_IQJQjs0Bw2eflt-nDE0aRn9cZWtw5lb0cpq78Mqo-DY0nw4faDgMtJs3ZzRQl_mRVOwOqyQmhmqZqFyXemSVnndUAwhCRUsplBoegtqf0JODg-O5wvWZ2JgFoxXDUsJSWu4iz08I6ORCA0EFKXOpSaKHaaNEdbD1ktPuPbaZlGWaG6k1S52qY2fks0ylO45oQKsY-xjh0Ri3FojE7zMFJZzA23FcpeMh9FXFx3hhhqQaOdqkJdCeSlMoMmhxnQQkvpt6iiwCv-s-3aQqgJp4GWJLl1oKjVB4rNUyijZJc86cd_2B5TiFFSX3PuPP78hW4vjr0u1_HT05QV5gF86lMxLslmvG_cKfJ3avG7n8g0iUf2v |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+effect+of+PLGA-based+hydrogel+scaffold+for+improving+the+drug+maximum-tolerated+dose+for+in+situ+osteosarcoma+treatment&rft.jtitle=Colloids+and+surfaces%2C+B%2C+Biointerfaces&rft.au=Yang%2C+Zhiming&rft.au=Yu%2C+Shuangjiang&rft.au=Li%2C+Dongsong&rft.au=Gong%2C+Yubao&rft.date=2018-12-01&rft.eissn=1873-4367&rft.volume=172&rft.spage=387&rft.epage=394&rft_id=info:doi/10.1016%2Fj.colsurfb.2018.08.048&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0927-7765&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0927-7765&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0927-7765&client=summon |